Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cilagicin in China, also supports custom service. Welcome to wholesale bulk high quality cilagicin from our factory. Contact us for more details.
| Description | Cilagicin is a dodeca-lipodepsipeptide antibiotic (MCE, molecular formula C68H103N15O21, molecular weight 1466.63 Da), originally discovered through bioinformatics analysis of the cil gene cluster in Paenibacillus mucilaginosus, and subsequently obtained by chemical synthesis. Cilagicin possesses a unique dual-function mechanism: it can chelate two different essential undecaprenyl phosphate lipid carriers - these carriers are indispensable transmembrane transporters in bacterial cell wall peptidoglycan and teichoic acid biosynthesis. By simultaneously blocking both carriers, Cilagicin efficiently inhibits cell wall biosynthesis. No detectable resistance development was observed in either laboratory tests or multidrug-resistant clinical isolates. It exhibits potent antibacterial activity against Gram-positive ESKAPE pathogens (including MRSA, VRE, etc.) with MIC ~1 ug/mL. Widely used in anti-MDR drug development, cell wall synthesis inhibitor mechanism research and genome mining-driven novel antibiotic discovery. |
| Structure type | Dodeca-lipodepsipeptide (fatty acid chain, lactone cyclization) |
| Solubility | Soluble in DMSO, methanol, DMF |
| Storage | Powder at -20C, dry, protected from light |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| Cilagicin | Cilagicin; streptococcal lantibiotic | Lantibiotic, Gram-positive targeting, antibiofilm, bacteriocin, anti-infection | Lantibiotic produced by Streptococcus salivarius, forming a compact cyclic structure with multiple lanthionine residues; inhibits cell wall synthesis via binding to lipid II, highly active against oral pathogens and biofilms | C₅₅H₇₉N₁₃O₁₄S₂ | 1193.53 | ~1194.6 | Free peptide | 18 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-CILAG | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. Soluble in dilute acetic acid and acidic buffers. Lantibiotic cyclic structure is protease-resistant and stable in the oral environment. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-CILAG | Lantibiotic cilagicin against oral pathogens and biofilms | Cilagicin is a lantibiotic from Streptococcus salivarius, with a compact cyclic structure containing multiple lanthionine residues. It binds lipid II to inhibit transpeptidation and transglycosylation, blocking cell wall synthesis. It is highly bactericidal against oral pathogens such as S. mutans and S. sanguinis, and effectively inhibits dental plaque biofilm formation and development. | Oral antibacterial, dental plaque biofilm inhibition, lantibiotics, streptococcal bacteriocins, oral care | Cell wall precursor lipid II; peptidoglycan synthesis inhibition; oral biofilm formation |
Hot Tags: cilagicin, China cilagicin manufacturers, suppliers, factory, 849352-44-9, antimicrobial peptides, CAS 143459 88 5, CAS 79404 91 4, CP7-FP13-2, Temporin K
